AMD’s CIO On AI-Driven Transformation And The Future Of IT
AMD CIO Hasmukh Ranjan has the company on the path to take full advantage of advances in artificial intelligence.
GEN11d
Wet AMD Treatments Could Work Better If Both VEGF and ANGPTL4 Are Targeted
Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...
ophthalmologytimes7d
Researchers offer insights into wet AMD: Study reveals potential to enhance anti-VEGF therapy with experimental drug to preserve vision
A Johns Hopkins study reveals that anti-VEGF treatments for wet AMD may unintentionally elevate ANGPTL4, a protein that ...
Live Science on MSN8d
LED device treats leading cause of vision loss with light therapy, FDA says
The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular ...
Medscape3d
Researchers Identify Why Some Don’t Respond to Anti-VEGF Drugs for AMD
Despite the introduction of therapies targeting VEGF, less than half of all treated patients with wet AMD, the most common ...
FierceBiotech9d
FDA clears its first treatment for dry AMD, with LumiThera's light-based Valeda system
The FDA has cleared its first light-based therapy for dry age-related macular degeneration—which the agency described as ...
Daily8d
FDA authorises marketing of light therapy as treatment of AMD
The US Food and Drug Administration has FDA has granted marketing authorization to a form of light therapy as the first-ever ...
Yahoo Finance10d
FDA authorises marketing of LumiThera’s dry AMD treatment device
This treatment is aimed at improving vision in dry AMD patients. LumiThera Regulatory Affairs vice-president Lori Holder said ...